These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7316509)

  • 21. Demonstration of the common antigens of Clostridium botulinum, C. sporogenes and C. novyi by an enzyme-linked immunosorbent assay and electroblot transfer.
    Poxton IR
    J Gen Microbiol; 1984 Apr; 130(4):975-81. PubMed ID: 6376703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):105-12. PubMed ID: 3884243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-linked immunosorbent assay (ELISA) for the detection and differentiation of Clostridium botulinum toxins type A and B.
    Michalik M; Grzybowski J; Ligieza J; Reiss J
    J Immunol Methods; 1986 Nov; 93(2):225-30. PubMed ID: 3095433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Clostridium botulinum types C and D toxin by ELISA.
    Thomas RJ
    Aust Vet J; 1991 Mar; 68(3):111-3. PubMed ID: 2043084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colony immunoblot assay of botulinal toxin.
    Goodnough MC; Hammer B; Sugiyama H; Johnson EA
    Appl Environ Microbiol; 1993 Jul; 59(7):2339-42. PubMed ID: 8357267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B.
    Szílagyi M; Rivera VR; Neal D; Merrill GA; Poli MA
    Toxicon; 2000 Mar; 38(3):381-9. PubMed ID: 10669027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Clostridium botulinum, Clostridium argentinense, and related organisms by cellular fatty acid analysis.
    Ghanem FM; Ridpath AC; Moore WE; Moore LV
    J Clin Microbiol; 1991 Jun; 29(6):1114-24. PubMed ID: 1864927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The enzyme-linked immunosorbent assay (ELISA) for the detection and determination of Clostridium botulinum toxins A, B, and E.
    Notermans S; Hagenaars AM; Kozaki S
    Methods Enzymol; 1982; 84():223-38. PubMed ID: 7048008
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay.
    Wictome M; Newton K; Jameson K; Hallis B; Dunnigan P; Mackay E; Clarke S; Taylor R; Gaze J; Foster K; Shone C
    Appl Environ Microbiol; 1999 Sep; 65(9):3787-92. PubMed ID: 10473376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sensitive and useful radioimmunoassay for neurotoxin and its haemagglutinin complex from Clostridium botulinum.
    Ashton AC; Crowther JS; Dolly JO
    Toxicon; 1985; 23(2):235-46. PubMed ID: 3895579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: collaborative study.
    Ferreira JL; Maslanka S; Johnson E; Goodnough M
    J AOAC Int; 2003; 86(2):314-31. PubMed ID: 12723917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium botulinum type D neurotoxin: purification and detection.
    De Jongh KS; Schwartzkoff CL; Howden ME
    Toxicon; 1989; 27(2):221-8. PubMed ID: 2655181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological detection of Clostridium botulinum toxin type A in therapeutic preparations.
    Ekong TA; McLellan K; Sesardic D
    J Immunol Methods; 1995 Mar; 180(2):181-91. PubMed ID: 7714333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinic toxin detection by counterimmunoelectrophoresis.
    Nuñez L; Amato de Lagarde EA; d'Aquino M
    Zentralbl Bakteriol; 1990 Mar; 272(3):290-3. PubMed ID: 2331296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative duplex PCR of Clostridium botulinum types A and B neurotoxin genes.
    Kasai Y; Kimura B; Tajima Y; Fujii T
    Shokuhin Eiseigaku Zasshi; 2007 Feb; 48(1):19-26. PubMed ID: 17370613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism.
    Dezfulian M; Hatheway CL; Yolken RH; Bartlett JG
    J Clin Microbiol; 1984 Sep; 20(3):379-83. PubMed ID: 6490825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro assays for botulinum toxin and antitoxins.
    Shone C; Appleton N; Wilton-Smith P; Hambleton P; Modi N; Gatley S; Melling J
    Dev Biol Stand; 1986; 64():141-5. PubMed ID: 3792644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantities of Clostridium botulinum organisms and toxin in feces and presence of Clostridium botulinum toxin in the serum of an infant with botulism.
    Paton JC; Lawrence AJ; Steven IM
    J Clin Microbiol; 1983 Jan; 17(1):13-5. PubMed ID: 6338033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of sensitive colorimetric capture ELISAs for Clostridium botulinum neurotoxin serotypes E and F.
    Poli MA; Rivera VR; Neal D
    Toxicon; 2002 Jun; 40(6):797-802. PubMed ID: 12175617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.